Literature DB >> 17112408

Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice.

Yan-jun Zhang1, Lei Zhang, Yi-lu Ye, San-hua Fang, Yu Zhou, Wei-ping Zhang, Yun-bi Lu, Er-qing Wei.   

Abstract

AIM: To determine whether cysteinyl leukotriene receptors (CysLT1 and CysLT2) are upregulated in acute neuronal injury after focal cerebral ischemia in mice, and to confirm CysLT1 receptor localization.
METHODS: After permanent focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO), neurological deficits and neuron loss were determined at various time points within 48 h. The mRNA expressions of CysLT1 and CysLT2 receptors in the brain were analyzed by RT-PCR. CysLT1 receptor localization was detected by double immunofluorescence.
RESULTS: Neurological deficits and neuron loss were found 6, 24 and 48 h after MCAO. The mRNA expressions of both CysLT1 and CysLT2 receptors were upregulated in the ischemic hemisphere 1, 24, and 48 h after MCAO with peaks at 24 h. The CysLT1 receptor was selectively localized in neurons 24 h after MCAO.
CONCLUSION: CysLT1 and CysLT2 receptors are upregulated in acute neuronal injury after focal cerebral ischemia, and the CysLT1 receptor is localized in neurons after ischemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112408     DOI: 10.1111/j.1745-7254.2006.00458.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice.

Authors:  Jing-Ran Lin; Shun-Chang Fang; Su-Su Tang; Mei Hu; Yan Long; Arijit Ghosh; Hong-Bin Sun; Ling-Yi Kong; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

2.  Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice.

Authors:  Xu-Ben Yu; Rong-Rong Dong; Hui Wang; Jing-Ran Lin; Yun-Qi An; Yong Du; Su-Su Tang; Mei Hu; Yan Long; Hong-Bin Sun; Ling-Yi Kong; Hao Hong
Journal:  Psychopharmacology (Berl)       Date:  2015-11-07       Impact factor: 4.530

3.  Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.

Authors:  Xue-Qin Huang; Xia-Yan Zhang; Xiao-Rong Wang; Shu-Ying Yu; San-Hua Fang; Yun-Bi Lu; Wei-Ping Zhang; Er-Qing Wei
Journal:  J Neuroinflammation       Date:  2012-06-26       Impact factor: 8.322

4.  Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.

Authors:  Bing Han; Yan-Yan Zhang; Ze-Qing Ye; Yun Xiao; Javad Rasouli; Wen-Cheng Wu; Su-Min Ye; Xin-Yue Guo; Lin Zhu; Abdolmohamad Rostami; Li-Bin Wang; Yuan Zhang; Xing Li
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

Review 5.  Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.

Authors:  Paolo Gelosa; Francesca Colazzo; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

6.  Hippocampal CysLT1R overexpression or activation accelerates memory deficits, synaptic dysfunction, and amyloidogenesis in young APP/PS1 transgenic mice.

Authors:  Shun-Chang Fang; Jun-Jie Wang; Fang Chen; Su-Su Tang; Rong-Hao Mu; Dan-Hua Yuan; Jia-Jia Zhao; Hao Hong; Yan Long
Journal:  Ann Transl Med       Date:  2021-10

7.  Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis.

Authors:  Jakob O Ström; Tobias Strid; Sven Hammarström
Journal:  BMC Neurosci       Date:  2012-11-30       Impact factor: 3.288

8.  Case Series Using Montelukast in Patients with Memory Loss and Dementia.

Authors:  Spencer I Rozin
Journal:  Open Neurol J       Date:  2017-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.